High Content Screening Market worth $615.8 Million by 2018 The global High Content Screening Market is a technology-driven market. Over the years, the technologies used as well as their adoption by contract research organizations (CROs) and academic and government institutes have witnessed a rapid change. The market demands significant investments in R&D in order to constantly come up with new innovative products and technologies. Through the development of innovative products, the players in the HCS market compete against each other in order to enhance their market shares. Browse more than 50 market data tables with 10 figures spread through 151 pages and in-depth TOC on "High Content Screening Market by Instruments (Cell Imaging and Analysis System), by Applications (Primary and Secondary Screening, Target Identification and Validation, Toxicity Studies, Compound Profiling), Software & Services - Global Forecasts to 2018". http://www.marketsandmarkets.com/Market-Reports/high-content-screening-market-42710391.html Early buyers will receive 10% customization on this report The global high content screening (HCS) market is segmented on the basis of products, applications, end users, and geography. The products market is further segmented into instruments, consumables, software, and services. Based on applications, the market is divided into primary and secondary screening, target identification and validation, toxicity studies, compound profiling, and other applications. Based on end users, the market is segmented into pharmaceutical and biotechnology companies, academic and government institutes, and contract research organizations (CROs). Based on geography, this market is divided into North America, Europe, Asia, and the Rest of the World (RoW).
A number of small and mid-sized emerging players and large players are present in the global HCS market. The degree of competiveness amongst these players is high. Moreover, many new players are entering this market, which is increasing the level of competition. At the same time, existing players are focusing on increasing their product differentiation to reduce competition and maintain their market share. Thermo Fisher Scientific (U.S.) is the market leader in the HCS instruments market. The company offers a wide range of high content screening products, such as cellular imaging instruments, software, and reagents to a large number of end users including clinical, healthcare, and pharmaceutical companies as well as academic institutions. The company has a wellestablished international network of warehouses, specialized product vaults, and warehouse management systems, which maintain inventory and coordinate product delivery. In addition, it has 12,600 sales and service personnel including more than 1,000 highly skilled technical specialists who meet the technical needs of the end users. The HCS consumables market does not have a market leader as the market is fragmented and is shared by many different players. Some of the prominent players in the HCS consumables market are Life Technologies (U.S.), Thermo Fisher Scientific (U.S.), Becton, Dickinson and Company (U.S.), Molecular Devices (U.S.), Cell Signaling Technologies (U.S.), PerkinElmer (U.S.), GE Healthcare (U.K.), Intellicyt Corporation (U.S.), and Merck KGaA (U.S.). Browse Related Report: High Throughput Screening (HTS) Market by Technology (Cell Based, Ultra High Throughput Screening (UHTS), Label Free, Bioinformatics), by Applications (Target Identification, Primary Screening, Toxicology, Stem Cell) & by End Users (Pharmaceutical Industry, Biotechnology Industry, CRO) - Forecast to 2018 http://www.marketsandmarkets.com/Market-Reports/high-throughput-screening-market-134981950.html